Literature DB >> 7363838

Topical corticosteroids: clinical pharmacology and therapeutic use.

J A Miller, D D Munro.   

Abstract

The development of topical corticosteroids has enabled many dermatoses to be more effectively treated than previously, but there is also no doubt that misuse of these preparations can lead to troublesome local effects and potentially serious systemic problems. The most effective assay for comparing different compounds has been their vasoconstrictive activity, and this on the whole correlates well with clinical effect. To be effective, corticosteroid must be absorbed and the importance of concentration, occlusion, the type of vehicle, added penetrants such as urea and the anatomical site, on the amount of absorption and therefore on clinical activity has been demonstrated. Ointments have been shown to be more effective than creams but because of the considerable choice of potencies now available most dermatologists tend to prescribe the different formulations according to the wishes of the patient. For the same reason, dilution of the commercially marketed preparations is now not generally recommended. The main therapeutic activity of topical corticosteroids is their nonspecific anti-inflammatory effect, thought to be primarily a result of their action on the chemical mediators of inflammation. They have also been shown to be antimitotic which may well be relevant not only to the treatment of scaling dermatoses but also to their dermal thinning effect resulting from inhibition of fibroblasts. Combinations of corticosteroids with antibacterial and antifungal agents have been shown to be very effective in flexural eruptions and secondarily infected dermatoses. As a general rule, the use of topical corticosteroids in outpatients, unless badly misused, is not associated with any significant risk of adrenal axis suppression, but care must be exercised as to the amount prescribed, especially if large areas of the body are to be treated with highly potent preparations. Certain groups such as young children and patients with liver failure, and certain anatomical sites such as the flexures and face appear much more prone to side effects, and in these cases mild or moderate compounds should be used in preference to the stronger preparations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7363838     DOI: 10.2165/00003495-198019020-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  40 in total

1.  In vivo percutaneous penetration of corticoids in man and unresolved problems in their efficacy.

Authors:  H I Maibach
Journal:  Dermatologica       Date:  1976

2.  Proposed mode of action of corticosteroids on the connective tissue.

Authors:  J C Houck; Y M Patel
Journal:  Nature       Date:  1965-04-10       Impact factor: 49.962

3.  Topically applied triamcinolone and macromolecular synthesis by human epidermis.

Authors:  R Marks; K Halprin; K Fukui; D Graff
Journal:  J Invest Dermatol       Date:  1971-06       Impact factor: 8.551

4.  The effect of percutaneously absorbed steroids on hypothalamic--pituitary--adrenal function after intensive use in in-patients.

Authors:  D D Munro
Journal:  Br J Dermatol       Date:  1976-03       Impact factor: 9.302

5.  Effects of local corticosteroids in skin infections.

Authors:  W Raab
Journal:  Dermatologica       Date:  1976

6.  A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate.

Authors:  D V Stevanovic; L Wilson; C G Sparkes
Journal:  Br J Dermatol       Date:  1977-01       Impact factor: 9.302

7.  Proprietary hydrocortisone creams. Vasoconstrictor activities and bio-availabilities of six preparations.

Authors:  B W Barry; R Woodford
Journal:  Br J Dermatol       Date:  1976-10       Impact factor: 9.302

8.  Vasoconstrictor activities and bio-availabilities of seven proprietary corticosteroid creams assessed using a non-occluded multiple dosage regimen; clinical implications.

Authors:  B W Barry; R Woodford
Journal:  Br J Dermatol       Date:  1977-11       Impact factor: 9.302

9.  Corticosteroid effect on epidermal cell size.

Authors:  C Delforno; P J Holt; R Marks
Journal:  Br J Dermatol       Date:  1978-06       Impact factor: 9.302

10.  Assay of topical corticosteroids. Efficacy of suppression of experimental Rhus dermatitis in humans.

Authors:  K H Kaidbey; A M Kligman
Journal:  Arch Dermatol       Date:  1976-06
View more
  6 in total

Review 1.  Topical corticosteroids. Which drug and when?

Authors:  B Giannotti; N Pimpinelli
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

Review 2.  Current treatment guidelines for topical corticosteroids.

Authors:  B Giannotti
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Transdermal drug administration--a nuisance becomes an opportunity.

Authors:  J E Shaw; J Urquhart
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-03

4.  Comparison of the effects of dexamethasone and 13-cis-retinoic acid on connective tissue biosynthesis in human skin fibroblasts.

Authors:  A Oikarinen; E Vuorio; T Vuorio
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

5.  Phimosis and topical steroids: new clinical findings.

Authors:  Nicola Zampieri; Michele Corroppolo; Veronica Zuin; Sanzio Bianchi; Francesco Saverio Camoglio
Journal:  Pediatr Surg Int       Date:  2007-02-17       Impact factor: 1.827

Review 6.  Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.

Authors:  M Mori; N Pimpinelli; B Giannotti
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.